The content is available as a PDF (312.4 KB).
letter . 2020 Sep 11:jjaa187. doi: 10.1093/ecco-jcc/jjaa187
Prevalence of COVID-19 Symptoms among Inflammatory Bowel Disease Patients Treated with Biological Agents
Thomas E Conley
1, Chris Probert
2, Sreedhar Subramanian
1,✉
Thomas E Conley
1
Department of Gastroenterology, Liverpool University Foundation Hospitals NHS Trust, Liverpool, UK
Find articles by Thomas E Conley
Chris Probert
2
Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Crown Street, Liverpool
Find articles by Chris Probert
Sreedhar Subramanian
1
Department of Gastroenterology, Liverpool University Foundation Hospitals NHS Trust, Liverpool, UK
Find articles by Sreedhar Subramanian
1
Department of Gastroenterology, Liverpool University Foundation Hospitals NHS Trust, Liverpool, UK
2
Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Crown Street, Liverpool
✉
Corresponding author: Sreedhar Subramanian, MD, MRCP, Consultant Gastroenterologist and Honorary Senior Lecturer, epartment of Gastroenterology, Liverpool University Hospital Foundation NHS Trust and University of Liverpool, Prescot Street, Liverpool L7 8XP, UK, Email: sreedhar.subramanian@liverpoolft.nhs.uk
Received 2020 Aug 11.
Keywords: Inflammatory bowel disease, biologics, Covid-19
© Crown copyright 2020.
This article contains public sector information licensed under the Open Government Licence v3.0 (http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/).
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC7543299 PMID: 32918090